BioCentury
ARTICLE | Financial News

Horizon surges on earnings upside

November 7, 2015 1:38 AM UTC

Horizon Pharma plc (NASDAQ:HZNP) jumped $3.74 (22%) to $21 on Friday after reporting 3Q15 EPS and revenues that shattered consensus estimates and boosting its full year sales guidance.Horizon reported adjusted diluted EPS of $0.70 on sales of $226.5 million. The Street was expecting 3Q15 EPS of $0.40 and sales of $185.7 million.

In 3Q14, the company reported EPS of $0.19 on sales of $75.1 million. ...